Pages that link to "Q34402067"

The following pages link to The biology of natural killer cells in cancer, infection, and pregnancy (Q34402067):

Displaying 45 items.

• Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface (Q24801311) (← links)
• Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy (Q24805285) (← links)
• Immunotherapeutic applications of NK cells (Q27015908) (← links)
• Adoptive cell therapies for glioblastoma (Q27030863) (← links)
• Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses (Q33343740) (← links)
• NK cell-based immunotherapy for malignant diseases (Q33827433) (← links)
• Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period (Q34143509) (← links)
• Basic aspects of implantation (Q34585834) (← links)
• The natural killer cell -- friend or foe in autoimmune disease? (Q34613914) (← links)
• Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells (Q35543911) (← links)
• Immune system effects of echinacea, ginseng, and astragalus: a review (Q35702399) (← links)
• Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 (Q35876978) (← links)
• Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain (Q35878535) (← links)
• Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. (Q35887319) (← links)
• Natural killer cells: can they be useful as adoptive immunotherapy for cancer? (Q36065944) (← links)
• A good manufacturing practice method to ex vivo expand natural killer cells for clinical use. (Q36187369) (← links)
• Potential therapeutic role of natural killer cells in cancer (Q36675436) (← links)
• Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation (Q37155165) (← links)
• Acupuncture as anticancer treatment? (Q37657657) (← links)
• Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer (Q37669516) (← links)
• Natural killer cells and tumor control (Q37786500) (← links)
• Natural killer cell lines in tumor immunotherapy (Q37998371) (← links)
• Cell transfer therapy for cancer: past, present, and future (Q38205228) (← links)
• Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer (Q38599353) (← links)
• Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101 (Q38602671) (← links)
• The antileukemic potential of natural killer cells (Q38773351) (← links)
• hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function (Q39140544) (← links)
• Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset (Q41699529) (← links)
• Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients (Q42439634) (← links)
• Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immu (Q42503288) (← links)
• Expression of concern--Mavoungou E. Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy. Clin Med Res 2006;4:33-41. (Q43058256) (← links)
• A single major chromosomal region controls natural killer cell-like activity in rainbow trout (Q44406144) (← links)
• Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients (Q44823723) (← links)
• Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice (Q46651853) (← links)
• The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells (Q47268388) (← links)
• Immune effects of nickel. (Q52286491) (← links)
• Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner. (Q54119583) (← links)
• Cytokine and surface receptor diversity of NK cells in resistant C3H/HeN and susceptible BALB/c mice with chronic Pseudomonas aeruginosa lung infection (Q59139147) (← links)
• Differential expression of perforin in cytotoxic lymphocyte in HIV/AIDS patients of China (Q64130553) (← links)
• Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour (Q73738699) (← links)
• Enhanced natural killer activity and production of pro-inflammatory cytokines in mice selected for high acute inflammatory response (AIRmax) (Q79428366) (← links)
• A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation (Q81881357) (← links)
• Preparation of highly activated natural killer cells for advanced lung cancer therapy (Q91906006) (← links)
• Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma (Q91959036) (← links)
• NADPH oxidase 5α promotes the formation of CD271 tumor-initiating cells in oral cancer (Q97539524) (← links)